Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Lyamina, S. Kalish, I. Malyshev (Moscow, Russian Federation). Regulation of immune response plasticity – A path to success in pulmonary diseases management. Eur Respir J 2012; 40: Suppl. 56, 810

Member's Comments

No comment yet.

Related content which might interest you: Physiological responses at critical load on resistance exercise – Effects of aging process Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Rhinitis – An early stage of the evolution of joint airways disease? Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Autoimmunity and pulmonary hypertension: a perspective Source: Eur Respir J 2005; 26: 1110-1118 Year: 2005 Ageing of the immune system: a contribution to lung disease? Source: Annual Congress 2012 - Searching for the secrets of senescence in the lung Year: 2012 Freeflowmetry – The new method of evaluation of the respiratory function phenotype Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Presentation by an expert: Interactions between innate immunity, inflammation and structural cells in pulmonary disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Prenatal priming on neonatal innate and adaptive immune responses by the farming environment Source: Annual Congress 2005 - Environmental factors, allergy and asthma Year: 2005 Monitoring PGD2 production in airway disease Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The "susceptibility to exacerbation" phenotype in COPD and response to pulmonary rehabilitation Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 Long term inhalatory therapy in asthma – Achieving control of the disease Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Freeflowmetry – The proposal of the new method of evaluation of the respiratory function phenotype Source: Annual Congress 2010 - Advances in lung function II Year: 2010 Relevance of innate immune responses to chronic airway diseases Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences Year: 2008 Interrelation between mTB multi drug-resistance and cytokine activity in pulmonary TB patients and mTB virulence Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 The adaptive immune system, autoimmunity and COPD: lessons from human studies Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD? Year: 2007 LSC 2012 abstract – FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells during bacterial infection Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 A model of poly IC-driven exacerbations of smoke-induced pulmonary inflammation – does it meet researchers needs? Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009